1. Khavjou, Olga, D. Phelps, and A. Leib. “Projections of cardiovascular disease prevalence and costs: 2015–2035.” Dallas: American Heart Association (2016).
Catheters are approved for drug refractory recurrent symptomatic paroxysmal atrial fibrillation,
when used with CARTO® 3
Systems (excluding NAVISTAR® RMT THERMOCOOL®Catheter).
Caution: US law restricts this device to sale by or on the order of a physician.
Important information: Prior to use, refer to the instructions for use supplied with this device for indications,
contraindications, side effects,
warnings and precautions.